----

----

**UNITEDSTATES****SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

----

**FORM8-K**

CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934

Date ofReport (Date of Earliest Event Reported): November 30,2004

THE CLOROXCOMPANY(Exact name of registrant as specified in itscharter)

| **Delaware**                          |
|---------------------------------------|
|  (State or other jurisdiction of |
| incorporation or organization)        |

****

| **1-07151**             | **31-0595760**                      |
|-------------------------|-------------------------------------|
| (CommissionFile Number) | (I.R.S.Employer Identification No.) |

**1221Broadway****,****Oakland, California****94612-1888******(Address of principal executiveoffices)    (Zip code)

**(510) 271-7000******(Registrant's telephone number, includingarea code)

----

(Formername or former address, if changed since last report)

Check the appropriate boxbelow if the Form 8-K filing is intended to simultaneously satisfythe filing obligation of the registrant under any of the followingprovisions (see General Instruction A.2.)

[ ]  Writtencommunications pursuant to Rule 425 Under the Securities Act (17CFR 230.425)

[ ]  Solicitingmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)

[ ]  Pre-commencementcommunications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

[ ]  Pre-commencementcommunications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

----

```

```

 

ITEM8.01  OTHER EVENTS

The information set forthin the Registrant’s press release regarding its proposedprivate placement of $1.65 billion aggregate principal amountof senior notes (the “Notes”), dated November 30, 2004,which is filed as exhibit 99.1 hereto, is incorporated herein byreference.

The information containedin this Current Report on Form 8-K is neither an offer to sell nora solicitation of an offer to buy any of the Notes. The Notes to beoffered will not be registered under the Securities Act of 1933, asamended (the “Securities Act”), or applicable statesecurities laws and may not be offered or sold in the United Statesabsent registration or an applicable exemption from theregistration requirements of the Securities Act.

ITEM9.01  FINANCIAL  STATEMENTS AND EXHIBITSSIGNATURES

(c)       Exhibits

Exhibit             Description

99.1                Press Release, dated November 30, 2004.

Pursuant to therequirements of the Securities Exchange Act of 1934, the registranthas duly caused this report to be signed on its behalf by theundersigned, thereunto duly authorized.

                                                                       THE CLOROX COMPANY

Date:  November 30,2004                              By: /s/ PAMELA FLETCHER

                                                                                   Pamela Fletcher

                                                                                   Vice President - Secretary

                                                                                   

----

EXHIBITINDEX

Exhibit             Description

99.1                Press Release, dated November 30, 2004.

                                              

****